KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molina Healthcare (MOH) Common Equity (2016 - 2025)

Molina Healthcare (MOH) has disclosed Common Equity for 16 consecutive years, with $4.1 billion as the latest value for Q4 2025.

  • Quarterly Common Equity fell 9.5% to $4.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 billion through Dec 2025, down 9.5% year-over-year, with the annual reading at $4.1 billion for FY2025, 9.5% down from the prior year.
  • Common Equity hit $4.1 billion in Q4 2025 for Molina Healthcare, down from $4.2 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $4.8 billion in Q2 2024 to a low of $2.2 billion in Q1 2021.
  • Historically, Common Equity has averaged $3.6 billion across 5 years, with a median of $3.8 billion in 2023.
  • Biggest five-year swings in Common Equity: skyrocketed 42.21% in 2023 and later dropped 12.14% in 2025.
  • Year by year, Common Equity stood at $2.6 billion in 2021, then rose by 12.7% to $3.0 billion in 2022, then surged by 42.21% to $4.2 billion in 2023, then increased by 6.67% to $4.5 billion in 2024, then decreased by 9.5% to $4.1 billion in 2025.
  • Business Quant data shows Common Equity for MOH at $4.1 billion in Q4 2025, $4.2 billion in Q3 2025, and $4.6 billion in Q2 2025.